The effect of aberrant expression and genetic polymorphisms of Rad21 on cervical cancer biology

Impact of genetic variations and transcriptional alterations of HLA class I genes on cervical cancer pathogenesis

(2017) Damayanti Das Ghosh et al.   INTERNATIONAL JOURNAL OF CANCER

Polymorphisms in mitotic checkpoint-related genes can influence survival outcomes of early-stage non-small cell lung cancer

(2017) Hyo Gyoung Kang et al.   Oncotarget

Genome-wide association study identifies four SNPs associated with response to platinum-based neoadjuvant chemotherapy for cervical cancer

(2017) Xiong Li et al.   Scientific Reports

Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties

(2017) Jialin Cai et al.   EBioMedicine

Mutant p53 stimulates cell invasion through an interaction with Rad21 in human ovarian cancer cells

(2017) Ji-Hye Ahn et al.   Scientific Reports

Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone

(2016) Irfana Muqbil et al.   CANCER LETTERS

Breaking the DNA damage response to improve cervical cancer treatment

(2016) Hylke W. Wieringa et al.   CANCER TREATMENT REVIEWS

The cohesin subunit Rad21 is a negative regulator of hematopoietic self-renewal through epigenetic repression of Hoxa7 and Hoxa9

(2016) J B Fisher et al.   LEUKEMIA

Importins and exportins as therapeutic targets in cancer

(2016) Amit Mahipal et al.   PHARMACOLOGY & THERAPEUTICS

Suppression of RAD21 Induces Senescence of MDA-MB-231 Human Breast Cancer Cells Through RB1 Pathway Activation Via c-Myc Downregulation

(2015) Shan Zhu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling

(2015) Johan A. den Boon et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas

(2014) S Deb et al.   BRITISH JOURNAL OF CANCER

Cohesin Rad21 Mediates Loss of Heterozygosity and Is Upregulated via Wnt Promoting Transcriptional Dysregulation in Gastrointestinal Tumors

(2014) Huiling Xu et al.   Cell Reports

A siRNA screen identifies RAD21 , EIF3H , CHRAC1 and TANC2 as driver genes within the 8q23, 8q24.3 and 17q23 amplicons in breast cancer with effects on cell growth, survival and transformation

(2013) Sardar Faisal Mahmood et al.   CARCINOGENESIS

p53 SUMOylation promotes its nuclear export by facilitating its release from the nuclear export receptor CRM1

(2013) Aleixo Santiago et al.   MOLECULAR BIOLOGY OF THE CELL

Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms

(2013) Ayana Kon et al.   NATURE GENETICS

Deregulation of RAD21 and RUNX1 expression in endometrial cancer

(2012) ANNA SUPERNAT et al.   Oncology Letters

Protein localization in disease and therapy

(2011) M.-C. Hung et al.   JOURNAL OF CELL SCIENCE

The nuclear export receptor XPO-1 supports primary miRNA processing in C. elegans and Drosophila

(2010) Ingo Büssing et al.   EMBO JOURNAL

Rad21-Cohesin Haploinsufficiency Impedes DNA Repair and Enhances Gastrointestinal Radiosensitivity in Mice

(2010) Huiling Xu et al.   PLoS One

CRM1 mediates nuclear-cytoplasmic shuttling of mature microRNAs

(2009) D. Castanotto et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer

(2008) Aurelia Noske et al.   CANCER

CRM1-Mediated Nuclear Export of Proteins and Drug Resistance in Cancer

(2008) Joel Turner et al.   CURRENT MEDICINAL CHEMISTRY

The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation

(2008) Pauline J. van der Watt et al.   INTERNATIONAL JOURNAL OF CANCER